Access the latest insights from the 32nd European Academy of Dermatology and Venereology 2023 Congress (EADV) in Berlin, Germany. This
Dr. Ronald Vender discusses TKY2 Inhibitors and explains their contribution to the initiation and chronicity of psoriasis.
Dr. Lluis Puig moderates a panel discussion with experts Richard Warren and Ronald Vender, covering section three lectures.
Access insights on patient adherence in psoriasis treatments, covering evolving therapies, oral agents, biologics, and phototherapy. Real-world data highlights the
Dr. Alexis Ogdie explores the potential of psoriasis treatment in either delaying or preventing the onset of psoriatic arthritis.
Dr. Mahira El-Sayed discusses the therapeutic challenges related to diagnosing and treating psoriasis in patients with skin of color.
Discover the latest updates on psoriasis from the World Congress of Dermatology (WCD) 2023, hosted in Singapore from July 3–8.
Dr. Angela Londoño discusses what has been learned about Methotrexate in the last 75 years.
La Dra. Ángela Londoño comenta lo
Dr. Gabriel Magariños discusses the role of small molecules in the treatment of psoriasis.
El Dr. Gabriel Magariños analiza el papel
Dr. Liao reviews his teams research on comparing the efficacy of biologic and oral treatments in PP and PPP.
